Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 2
2013 7
2014 10
2015 8
2016 13
2017 7
2018 5
2019 5
2020 12
2021 9
2022 12
2023 16
2024 2
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 and atrial fibrillation: Intercepting lines.
Donniacuo M, De Angelis A, Rafaniello C, Cianflone E, Paolisso P, Torella D, Sibilio G, Paolisso G, Castaldo G, Urbanek K, Rossi F, Berrino L, Cappetta D. Donniacuo M, et al. Among authors: rafaniello c. Front Cardiovasc Med. 2023 Jan 23;10:1093053. doi: 10.3389/fcvm.2023.1093053. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36755799 Free PMC article. Review.
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data.
Zinzi A, Gaio M, Liguori V, Cagnotta C, Paolino D, Paolisso G, Castaldo G, Nicoletti GF, Rossi F, Capuano A, Rafaniello C. Zinzi A, et al. Among authors: rafaniello c. Pharmacol Res. 2023 Apr;190:106742. doi: 10.1016/j.phrs.2023.106742. Epub 2023 Mar 22. Pharmacol Res. 2023. PMID: 36963592 Free article.
Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview.
Crucitta S, Cucchiara F, Sciandra F, Cerbioni A, Diodati L, Rafaniello C, Capuano A, Fontana A, Fogli S, Danesi R, Re MD. Crucitta S, et al. Among authors: rafaniello c. Anticancer Agents Med Chem. 2022;22(4):760-774. doi: 10.2174/1871520621666210804100547. Anticancer Agents Med Chem. 2022. PMID: 34348634 Review.
Current pharmacological treatments for COVID-19: What's next?
Scavone C, Brusco S, Bertini M, Sportiello L, Rafaniello C, Zoccoli A, Berrino L, Racagni G, Rossi F, Capuano A. Scavone C, et al. Among authors: rafaniello c. Br J Pharmacol. 2020 Nov;177(21):4813-4824. doi: 10.1111/bph.15072. Epub 2020 May 15. Br J Pharmacol. 2020. PMID: 32329520 Free PMC article. Review.
Therapeutic strategies to fight COVID-19: Which is the status artis?
Scavone C, Mascolo A, Rafaniello C, Sportiello L, Trama U, Zoccoli A, Bernardi FF, Racagni G, Berrino L, Castaldo G, Coscioni E, Rossi F, Capuano A. Scavone C, et al. Among authors: rafaniello c. Br J Pharmacol. 2022 May;179(10):2128-2148. doi: 10.1111/bph.15452. Epub 2021 May 7. Br J Pharmacol. 2022. PMID: 33960398 Free PMC article. Review.
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis.
Gaio M, Vastarella MG, Sullo MG, Scavone C, Riccardi C, Campitiello MR, Sportiello L, Rafaniello C. Gaio M, et al. Among authors: rafaniello c. Pharmaceuticals (Basel). 2024 Jul 7;17(7):904. doi: 10.3390/ph17070904. Pharmaceuticals (Basel). 2024. PMID: 39065754 Free PMC article.
104 results